Episode 9: Suvorexant

Home / Medication Minute / Episode 9: Suvorexant

Today’s episode is part of my Medication Minute series. As previously described, these shorter episodes feature information regarding a specific subset of psychiatric medication management. On today’s episode, I want to discuss a newer medication called suvorexant, or trade name Belsomra, an orexin antagonist that was FDA-approved for treatment of insomnia.

References

  1. Bonnet, MH PhD, DL Arand PhD. “Treatment of insomnia in adults.” UpToDate, 10 August 2017. Web. 23 August 2017.
  2. Yang, Lily P.H. “Suvorexant: First Global Approval.” Drugs, vol. 74, no. 15, 2014, pp. 1817-1822., doi:10.1007/s40265-014-0294-5.
  3. “Suvorexant.” Wikipedia, Wikimedia Foundation, 9 Aug. 2017, en.wikipedia.org/wiki/Suvorexant.
  4. “Suvorexant: Drug Information.” UpToDate, 2017. Web. 23 August 2017.
  5. Vermeeren, Annemiek, et al. “On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 Mg: A Study in Non-Elderly Healthy Volunteers.” Sleep, vol. 38, no. 11, 2015, pp. 1803–1813., doi:10.5665/sleep.5168.